Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2001 Jun;85(6):670–672. doi: 10.1136/bjo.85.6.670

Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children

Y Fujii 1, H Tanaka 1, M Ito 1
PMCID: PMC1724019  PMID: 11371485

Abstract

BACKGROUND/AIMS—Postoperative vomiting occurs frequently after strabismus surgery in children. Granisetron, a selective 5-hydroxytryptamine type 3 receptor antagonist, is effective for the prevention of vomiting following paediatric strabismus surgery. Ramosetron, another new antagonist of 5-hydroxytryptamine type 3 receptor, has more potent and longer acting properties than granisetron against cisplatin induced emesis. This study was undertaken to compare the efficacy and safety of granisetron and ramosetron for the prevention of vomiting following strabismus surgery in children.
METHODS—In a randomised, double blinded manner 80 children, aged 4-10 years, received intravenously granisetron 40 µg/kg or ramosetron 6 µg/kg (n=40 each) at the end of surgery. A standard general anaesthetic technique and postoperative analgesia were used. Emetic episodes and safety assessment were performed during the first 24 hours and the next 24 hours after anaesthesia.
RESULTS—The percentage of patients who were emesis free during 0-24 hours after anaesthesia was 85% with granisetron and 90% with ramosetron, respectively (p = 0.369); the corresponding rate during 24-48 hours after anaesthesia was 70% and 95% (p = 0.003). No clinically serious adverse events caused by the study drug were observed in any of the groups.
CONCLUSION—Prophylactic antiemetic therapy with ramosetron is comparable with granisetron for the prevention of vomiting during 0-24 hours after anaesthesia in children undergoing strabismus surgery. During 24-48 hours after anaesthesia, ramosetron is more effective than granisetron for prophylaxis against postoperative vomiting.



Full Text

The Full Text of this article is available as a PDF (110.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramowitz M. D., Oh T. H., Epstein B. S., Ruttimann U. E., Friendly D. S. The antiemetic effect of droperidol following outpatient strabismus surgery in children. Anesthesiology. 1983 Dec;59(6):579–583. doi: 10.1097/00000542-198312000-00021. [DOI] [PubMed] [Google Scholar]
  2. Aspinall R. L., Goodman N. W. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ. 1995 Sep 30;311(7009):844–846. doi: 10.1136/bmj.311.7009.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bermudez J., Boyle E. A., Miner W. D., Sanger G. J. The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer. 1988 Nov;58(5):644–650. doi: 10.1038/bjc.1988.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carmichael J., Cantwell B. M., Edwards C. M., Zussman B. D., Thompson S., Rapeport W. G., Harris A. L. A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer Chemother Pharmacol. 1989;24(1):45–49. doi: 10.1007/BF00254104. [DOI] [PubMed] [Google Scholar]
  5. Fujii Y., Saitoh Y., Tanaka H., Toyooka H. Comparison of ramosetron and granisetron for preventing postoperative nausea and vomiting after gynecologic surgery. Anesth Analg. 1999 Aug;89(2):476–479. doi: 10.1097/00000539-199908000-00043. [DOI] [PubMed] [Google Scholar]
  6. Fujii Y., Tanaka H., Toyooka H. Granisetron reduces vomiting after strabismus surgery and tonsillectomy in children. Can J Anaesth. 1996 Jan;43(1):35–38. doi: 10.1007/BF03015955. [DOI] [PubMed] [Google Scholar]
  7. Fujii Y., Toyooka H., Tanaka H. Effective dose of granisetron for preventing postoperative emesis in children. Can J Anaesth. 1996 Jul;43(7):660–664. doi: 10.1007/BF03017947. [DOI] [PubMed] [Google Scholar]
  8. Kamato T., Ito H., Nagakura Y., Nishida A., Yuki H., Yamano M., Miyata K. Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets. Eur J Pharmacol. 1993 Jul 20;238(2-3):369–376. doi: 10.1016/0014-2999(93)90868-i. [DOI] [PubMed] [Google Scholar]
  9. Lerman J., Eustis S., Smith D. R. Effect of droperidol pretreatment on postanesthetic vomiting in children undergoing strabismus surgery. Anesthesiology. 1986 Sep;65(3):322–325. [PubMed] [Google Scholar]
  10. Warner L. O., Rogers G. L., Martino J. D., Bremer D. L., Beach T. P. Intravenous lidocaine reduces the incidence of vomiting in children after surgery to correct strabismus. Anesthesiology. 1988 Apr;68(4):618–621. doi: 10.1097/00000542-198804000-00026. [DOI] [PubMed] [Google Scholar]
  11. Watcha M. F., White P. F. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992 Jul;77(1):162–184. doi: 10.1097/00000542-199207000-00023. [DOI] [PubMed] [Google Scholar]
  12. Yarker Y. E., McTavish D. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs. 1994 Nov;48(5):761–793. doi: 10.2165/00003495-199448050-00008. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES